These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 215812)
1. [High molecular weight substances which inhibit calcium oxalate crystal growth. 1: Relative potencies of various kinds of urinary inhibitors which were determined new assay method (author's transl)]. Ito H; Shimazaki J Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1334-41. PubMed ID: 215812 [No Abstract] [Full Text] [Related]
2. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro. Ryall RL; Harnett RM; Marshall VR Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523 [TBL] [Abstract][Full Text] [Related]
3. [High molecular weight substances which inhibit calcium oxalate crystal growth. 4: Studies on the role of urinary pepsinogen and mucopolysaccharide as inhibitors of calcium oxalate crystal growth (author's transl)]. Ito H; Shimazaki J Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1355-9. PubMed ID: 153421 [No Abstract] [Full Text] [Related]
4. [High molecular weight substances which inhibit calcium oxalate crystal growth, 3: Studies on the characteristics of high molecular weight substances which inhibit calcium oxalate crystal growth (author's transl)]. Ito H; Shimazaki J Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1349-54. PubMed ID: 732069 [No Abstract] [Full Text] [Related]
5. [High molecular weight substances which inhibit calcium oxalate crystal growth. 2: Isolation and identification of a calcium oxalate crystal growth inhibitor from rat liver (author's transl)]. Ito H; Shimazaki J Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1342-8. PubMed ID: 732068 [No Abstract] [Full Text] [Related]
6. Risk factors for urinary calcium oxalate crystals as revealed by their specific enzymatic assay. Hallson PC; Rose GA Br J Urol; 1989 Nov; 64(5):451-7. PubMed ID: 2611612 [TBL] [Abstract][Full Text] [Related]
7. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi]. Boruczkowska A Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956 [TBL] [Abstract][Full Text] [Related]
8. [Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer]. Ebisuno S; Miyata K; Kohjimoto Y; Ohkawa T Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):339-44. PubMed ID: 8464186 [TBL] [Abstract][Full Text] [Related]
9. Urinary inhibitor of the formation of calcium oxalate. Sutor DJ; Percival JM; Doonan S Br J Urol; 1979 Aug; 51(4):253-5. PubMed ID: 223711 [TBL] [Abstract][Full Text] [Related]
10. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion. Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512 [TBL] [Abstract][Full Text] [Related]
12. Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine. Hallson PC; Rose GA; Sulaiman S Urol Int; 1983; 38(3):179-81. PubMed ID: 6868215 [TBL] [Abstract][Full Text] [Related]
13. Effect of inhibitors on the crystal growth of calcium oxalate. Minero C; Maggiorotti P; Barbeni M; Pelizzetti E; Tizzani A; Casetta G; Piana P; Giona C Contrib Nephrol; 1987; 58():65-72. PubMed ID: 3691149 [No Abstract] [Full Text] [Related]
14. [Urine saturation with calcium oxalate in urolithiasis]. Bogado CE; Zanchetta JR Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787 [No Abstract] [Full Text] [Related]
15. An assay method for the measurement of urinary inhibitors of calcium phosphate formation. Sutor DJ; Percival JM Clin Chim Acta; 1978 Oct; 89(2):256-72. PubMed ID: 213212 [TBL] [Abstract][Full Text] [Related]
16. [Studies on urinary calcium ion activity in urolithiasis, 2. The relationship to calcium oxalate crystal formation and the effects of magnesium and citrate]. Morimoto S Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):998-1005. PubMed ID: 4079203 [No Abstract] [Full Text] [Related]
17. Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy. Schwille PO; Scholz D; Hanisch E; Zeuner E; Schwendtner H; Husemann B; Mühe E; Sigel A Klin Wochenschr; 1983 Sep; 61(17):845-50. PubMed ID: 6632726 [TBL] [Abstract][Full Text] [Related]
18. Idiopathic calcium oxalate urinary lithiasis: usefulness of Parks' and Tiselius' indices in the evaluation of the risk of stone formation. Robert M; Roux JO; Boularan AM; Bourelly F; Monnier L; Grasset D Urol Int; 1995; 55(2):88-92. PubMed ID: 8533202 [TBL] [Abstract][Full Text] [Related]
19. [Growth of calcium oxalate crystals in vitro: a simple method for measurement of the inhibitory action of human urine (author's transl)]. Hess B; Binswanger U J Clin Chem Clin Biochem; 1981 May; 19(5):295-9. PubMed ID: 7264571 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis. Grases F; Genestar C; Conte A; March P; Costa-Bauzá A Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]